Anti-inflammatory dopamine- and serotonin-based endocannabinoid epoxides reciprocally regulate cannabinoid receptors and the TRPV1 channel
W. R. Arnold, L. N. Carnevale, Z. Xie, J. L. Baylon, E. Tajkhorshid, H. Hu, A. Das
This paper identifies novel endocannabinoid epoxides that modulate TRPV1 and cannabinoid receptors, reducing inflammation and offering potential for new therapeutics.
bioRxiv · May 5, 2020Biochemistry